Prostacyclin in blood vessel–platelet interactions: perspectives and questions
- 1 May 1979
- journal article
- Published by Springer Nature in Nature
- Vol. 279 (5708) , 14-15
- https://doi.org/10.1038/279014a0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Platelet and Blood Vessel Arachidonate Metabolism and InteractionsJournal of Clinical Investigation, 1979
- Prostacyclin is a circulating hormoneNature, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart.Proceedings of the National Academy of Sciences, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Prostaglandin release from vasculature by angiotensin II: Dissociation from lipolysisEuropean Journal of Pharmacology, 1973